KPV
Also called lysine-proline-valine, KPV tripeptide
KPV is the small, active tail of a natural hormone (alpha-MSH), and it's basically a targeted "calm down" signal for inflammation.
The published research here is animal and laboratory work. The ranges below come from community-reported dosing and results — what people have settled on in practice, and what they report happening.
- Gut health
- Immune
- Skin & hair
The quick answer
KPV is the small, active tail of a natural hormone (alpha-MSH), and it's basically a targeted "calm down" signal for inflammation. Because it's so small it slips right into cells and quiets the master inflammation switch - without the tanning or appetite effects of the full hormone.
People reach for it for gut flare-ups, irritated skin, and histamine or MCAS-type symptoms, usually noticing a difference within a few days to a couple of weeks. It clears the body fast, so splitting the dose is common. Two honest notes: most of the evidence is still from lab and animal studies, and purity in this corner of the market varies a lot - so a real COA matters here more than most.
Why people use it
🔥 Calms inflammation body-wide; 🩹 Eases gut issues (IBD, colitis); 🧴 Soothes inflamed skin; 🤧 Helps histamine and MCAS symptoms; ✅ No tanning or appetite side effects
What people report using
These are ranges other people have reported running. They are here so you can see what has actually been done — they are not medical advice and not a recommendation for you.
- How often
- Every day
- Route
- subcutaneous
- Evidence for this
- Animal and lab research
Used when a flare is stubborn or the standard dose has plateaued.
- How often
- Every day
- Route
- subcutaneous
- Evidence for this
- Animal and lab research
Gut complaints settling, skin calming, joint niggles easing.
10mg vial + 2mL bacteriostatic water (0.9% benzyl alcohol) = 5mg/mL. Add slowly down the glass side, roll gently, do not shake. 0.25mg = 5 units (0.05mL) on a U-100 insulin syringe. under the skin (abdomen 2in from navel, thigh, upper arm). Refrigerate after mixing (2–8°C); use within ~28 days. Draw KPV separately — do not mix in the same vial with other peptides.
Work out your own units on the reconstitution calculator — the most common serious mistake in this area is arithmetic, not chemistry.
What to expect, and when
- First thing people notice
- Days 3–7 (gut/skin comfort)
- When it gets real
- Weeks 1–2 (inflammation)
- Where it peaks
- Weeks 3–4 (steady state)
- Patience needed
- Low–Medium - mostly preclinical
- Days 1–3Uptake and signaling
KPV corresponds to the last three residues of alpha-MSH and is studied for anti-inflammatory action without the pigment effects of the parent hormone. Research shows it is taken into intestinal cells via the PepT1 transporter and acts largely receptor-independently on NF-κB signaling. Early on this is molecular activity, not a felt change. Preclinical framing only - there are no completed human trials.
- Days 3–7Early gut and skin comfort
In colitis models KPV lowers inflammatory cytokine output by dampening NF-κB and MAP-kinase signaling. Users commonly report early reductions in gut or skin irritation in this window, though this is anecdotal. Notably, PepT1 is upregulated in inflamed colon tissue, which researchers think helps target the effect where inflammation is highest. Keep expectations modest and preliminary.
- Weeks 1–2Inflammation settles further
Animal colitis studies show reduced disease severity, better weight recovery, and lower colonic cytokine levels with continued oral KPV. Users often report that gut or inflammatory-skin symptoms feel more consistently calm across these weeks. The described mechanism is a quieting of a master inflammatory switch rather than a targeted repair effect. All of this remains research-context, not a validated human result.
- Weeks 3–4Steady anti-inflammatory state
With ongoing exposure, preclinical evidence points to a sustained anti-inflammatory environment rather than an escalating one - the effect plateaus rather than building indefinitely. This is the window users most often describe as their steady baseline. Because no human clinical trials have been completed, confidence in any human timeline is low. Regard the whole arc as educational, not prescriptive.
Evidence is essentially all preclinical (cell and animal models); there are no completed human clinical trials, so any human timeline is inferred and uncertain.
Side effects, and what people do about them
One of the gentlest here. It's an anti-inflammatory with none of the tanning or appetite effects of the hormone it comes from, so most people notice little more than a mild injection-site reaction. Easy-going, whether injected or taken orally for gut support.
Go deeper
Open these only if you want them.
How it actually works
The final three amino acids - lysine-proline-valine - of alpha-MSH, the hormone that also drives pigmentation. This fragment keeps the anti-inflammatory activity and loses the pigmentation, and the reason appears to be that it works intracellularly, dampening NF-kB signalling, rather than through the melanocortin receptors on the cell surface.
For stacking, that is the clean distinction from melanotan: both are pieces of the same parent hormone, but melanotan is the receptor-binding pigment half and KPV is the intracellular inflammatory half. They do not compete, and neither produces the other's effect.
What people report, in full
Community feedback on KPV is still fairly limited, but among people using it for inflammation the common report is fast relief - a noticeable drop in acute gut or localized swelling within one to three days.
Sources and review
https://pubmed.ncbi.nlm.nih.gov/18092346/
https://pubmed.ncbi.nlm.nih.gov/18061177/
Last reviewed 2026-09-06.
People also look at
Still not sure?
Ask it the way you would ask a person. Follow-up questions are the point — it remembers what you already said.
Ask about KPV